{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:17:14Z","timestamp":1780481834629,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","academicradiology.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.acra.2023.09.004","type":"journal-article","created":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T20:43:39Z","timestamp":1697575419000},"page":"1950-1958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prostatic Urethral Length on MRI Potentially Predicts Late Genitourinary Toxicity After Prostate Cancer Radiation"],"prefix":"10.1016","volume":"31","author":[{"given":"Joseph","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirisha","family":"Nandalur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Hazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayf","family":"Al-Katib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Kolderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Marvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran R.","family":"Nandalur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2023.09.004_bib1","unstructured":"National Cancer Institute. Cancer stat facts: prostate cancer. Available at:\u00a0\u3008https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html\u3009. Published 2023. Accessed July 26, 2023."},{"key":"10.1016\/j.acra.2023.09.004_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.14674","article-title":"Trends in diagnosis and disparities in initial management of high-risk prostate cancer in the US","volume":"3","author":"Agrawal","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.acra.2023.09.004_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.1439","article-title":"Time trends and variation in the use of active surveillance for management of low-risk prostate cancer in the US","volume":"6","author":"Cooperberg","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.acra.2023.09.004_bib4","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s00345-022-04124-x","article-title":"Incidence of genitourinary complications following radiation therapy for localised prostate cancer","volume":"40","author":"David","year":"2022","journal-title":"World J Urol"},{"key":"10.1016\/j.acra.2023.09.004_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.6004\/jnccn.2019.7306","article-title":"Current status of MRI and PET in the NCCN guidelines for prostate cancer","volume":"17","author":"Mason","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.acra.2023.09.004_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2021.06.037","article-title":"Radiation dose to the intraprostatic urethra correlates strongly with urinary toxicity after prostate stereotactic body radiation therapy: a combined analysis of 23 prospective clinical trials","volume":"112","author":"Leeman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib7","article-title":"Urinary outcomes for men with high baseline international prostate symptom scores treated with prostate SBRT","volume":"6","author":"Gorovets","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib8","article-title":"Predictors for late genitourinary toxicity in men receiving radiotherapy for high-risk prostate cancer using planned and accumulated dose","volume":"25","author":"Li Kuan Ong","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib9","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.radonc.2015.06.011","article-title":"Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial","volume":"116","author":"Yahya","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamaoncol.2022.6558","article-title":"Magnetic resonance imaging-guided vs computed tomography-guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial","volume":"9","author":"Kishan","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijrobp.2022.01.022","article-title":"Intraprostatic urethra: the new kid on the block for prostate cancer radiation therapy?","volume":"113","author":"Zilli","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib12","first-page":"743","article-title":"Nomograms to predict late urinary toxicity after prostate cancer radiotherapy","volume":"32","author":"Mathieu","year":"2014","journal-title":"World J Urol"},{"key":"10.1016\/j.acra.2023.09.004_bib13","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S1470-2045(22)00544-7","article-title":"Mechanisms, mitigation, and management of urinary toxicity from prostate radiotherapy","volume":"23","author":"Martin","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2007.05.051","article-title":"Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer","volume":"70","author":"Pinkawa","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib15","first-page":"29","article-title":"Effect of pretreatment prostate volume on urinary quality of life following intensity-modulated radiation therapy for localized prostate cancer","volume":"5","author":"Chevli","year":"2013","journal-title":"Res Rep Urol"},{"key":"10.1016\/j.acra.2023.09.004_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ijrobp.2010.06.009","article-title":"Pretreatment nomogram to predict the risk of acute urinary retention after I-125 prostate brachytherapy","volume":"81","author":"Roeloffzen","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/pros.24457","article-title":"Impact of the bladder detrusor muscular ring on lower urinary tract symptoms due to benign prostatic hyperplasia: a quantitative MRI analysis","volume":"83","author":"Nandalur","year":"2023","journal-title":"Prostate"},{"issue":"5","key":"10.1016\/j.acra.2023.09.004_bib18","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.acra.2020.03.017","article-title":"Quantitative characterization of the prostatic urethra using MRI: implications for lower urinary tract symptoms in patients with benign prostatic hyperplasia","volume":"28","author":"Sanford","year":"2021","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2023.09.004_bib19","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/pros.24207","article-title":"Benign prostate hyperplasia as a potential protective factor against prostate cancer: insights from a magnetic resonance imaging study of compositional characteristics","volume":"81","author":"Nandalur","year":"2021","journal-title":"Prostate"},{"key":"10.1016\/j.acra.2023.09.004_bib20","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.clinimag.2021.09.003","article-title":"Which measurement method should be used for prostate volume for PI-RADS? A comparison of ellipsoid and segmentation methods","volume":"80","author":"Colvin","year":"2021","journal-title":"Clin Imaging"},{"key":"10.1016\/j.acra.2023.09.004_bib21","unstructured":"PRO-CTCA Measurement System.\u00a0Access date: July 2023, Available at:\u00a0\u3008https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/instruments\/pro-ctcae\/pro-ctcae_english.pdf\u3009."},{"key":"10.1016\/j.acra.2023.09.004_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","article-title":"Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature","volume":"61","author":"Budaus","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.acra.2023.09.004_bib23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ijrobp.2009.06.078","article-title":"External beam radiation therapy after transurethral resection of the prostate: a report on acute and late genitourinary toxicity","volume":"77","author":"Devisetty","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib24","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.ijrobp.2007.04.076","article-title":"Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study","volume":"69","author":"Harsolia","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.8006","article-title":"Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer","volume":"2","author":"Kishan","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.acra.2023.09.004_bib26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","article-title":"Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy","volume":"61","author":"Peeters","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.0039","article-title":"Effect of standard vs dose-escalated radiation therapy for patients with intermediate-risk prostate cancer: the NRG oncology RTOG 0126 randomized clinical trial","volume":"4","author":"Michalski","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S1470-2045(16)30102-4","article-title":"Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial","volume":"17","author":"Dearnaley","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41391-022-00520-x","article-title":"Long term genitourinary toxicity following curative intent intensity-modulated radiotherapy for prostate cancer: a systematic review and meta-analysis","volume":"26","author":"David","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.acra.2023.09.004_bib30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.ijrobp.2017.01.008","article-title":"ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam boost for high- and intermediate-risk prostate cancer","volume":"98","author":"Rodda","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ijrobp.2008.05.022","article-title":"Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients","volume":"73","author":"Keyes","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4111\/icu.2016.57.5.309","article-title":"Urethral strictures after radiation therapy for prostate cancer","volume":"57","author":"Moltzahn","year":"2016","journal-title":"Investig Clin Urol"},{"key":"10.1016\/j.acra.2023.09.004_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1148\/radiol.210500","article-title":"Preoperative prostate MRI predictors of urinary continence following radical prostatectomy","volume":"303","author":"Lamberg","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2023.09.004_bib34","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijrobp.2008.11.006","volume":"75","author":"Ishiyama","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.acra.2023.09.004_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.brachy.2011.09.008","article-title":"American brachytherapy society consensus guidelines for high-dose-rate prostate brachytherapy","volume":"11","author":"Yamada","year":"2012","journal-title":"Brachytherapy"},{"key":"10.1016\/j.acra.2023.09.004_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2021.12.027","article-title":"Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiotherapy for prostate cancer in the FLAME trial","volume":"167","author":"Groen","year":"2022","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.acra.2023.09.004_bib37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3322\/caac.21689","article-title":"Radiation therapy-associated toxicity: etiology, management, and prevention","volume":"71","author":"Wang","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.acra.2023.09.004_bib38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.radonc.2021.12.040","article-title":"Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation","volume":"167","author":"Kishan","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.acra.2023.09.004_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2015.07.048","article-title":"Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: results of a cohort study","volume":"116","author":"Cozzarini","year":"2015","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.acra.2023.09.004_bib40","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.acra.2022.01.009","article-title":"Development of a 3D CNN-based AI model for automated segmentation of the prostatic urethra","volume":"29","author":"Belue","year":"2022","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2023.09.004_bib41","doi-asserted-by":"crossref","DOI":"10.1148\/rg.220096","article-title":"MRI of benign prostatic hyperplasia: important pre- and posttherapeutic considerations","volume":"43","author":"Han","year":"2023","journal-title":"Radiographics"},{"issue":"7","key":"10.1016\/j.acra.2023.09.004_bib42","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.acra.2021.09.012","article-title":"Can pre-treatment quantitative multi-parametric MRI predict the outcome of radiotherapy in patients with prostate cancer?","volume":"29","author":"Chatterjee","year":"2022","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2023.09.004_bib43","doi-asserted-by":"crossref","first-page":"852","DOI":"10.2214\/AJR.22.28665","article-title":"PI-RR: the prostate imaging for recurrence reporting system for MRI assessment of local prostate cancer recurrence after radiation therapy or radical prostatectomy-a review","volume":"220","author":"Abreu-Gomez","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.acra.2023.09.004_bib44","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1148\/rg.2018170147","article-title":"Multiparametric MR imaging of the prostate after treatment of prostate cancer","volume":"38","author":"Patel","year":"2018","journal-title":"Radiographics"},{"key":"10.1016\/j.acra.2023.09.004_bib45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1148\/radiol.10092314","article-title":"Locally recurrent prostate cancer after external beam radiation therapy: diagnostic performance of 1.5-T endorectal MR imaging and MR spectroscopic imaging for detection","volume":"256","author":"Westphalen","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2023.09.004_bib46","doi-asserted-by":"crossref","DOI":"10.1148\/rycan.2020200007","article-title":"Biparametric MRI prior to radical radiation therapy for prostate cancer in a caribbean population: implications for risk group stratification and treatment","volume":"2","author":"Gosein","year":"2020","journal-title":"Radiol Imaging Cancer"},{"key":"10.1016\/j.acra.2023.09.004_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1148\/radiol.2020202747","article-title":"MRI-guided radiation therapy: an emerging paradigm in adaptive radiation oncology","volume":"298","author":"Otazo","year":"2021","journal-title":"Radiology"},{"issue":"8","key":"10.1016\/j.acra.2023.09.004_bib48","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.acra.2015.02.006","article-title":"Prostate MRI can reduce overdiagnosis and overtreatment of prostate cancer","volume":"22","author":"Rosenkrantz","year":"2015","journal-title":"Acad Radiol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633223004713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633223004713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T02:19:04Z","timestamp":1715134744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633223004713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1076633223004713"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2023.09.004","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostatic Urethral Length on MRI Potentially Predicts Late Genitourinary Toxicity After Prostate Cancer Radiation","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2023.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Association of University Radiologists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}